SHPH

Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has 6 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 15, 2026.

The most active filer is 10% Owner HRT FINANCIAL LP with 11 filings. Insiders have net sold $323K over the trailing 6 months.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Christopher Robert Cooper
  • Employees:9
  • HQ:Gaithersburg, MD, US
  • IPO:2022-08-31

Insider Buying

$182K

reported purchases (SEC code P)

Insider Selling

$505K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$20.8M

latest known value

Source
Sale$5KJul 15SEC ↗
Sale$368KJul 15SEC ↗
Purchase$28KJul 13SEC ↗
Purchase$2KJul 13SEC ↗
Sale$35KJul 9SEC ↗
Sale$65KJul 9SEC ↗
Purchase$28KJul 7SEC ↗
Sale$32KJul 7SEC ↗
Purchase$13KJul 2SEC ↗
Purchase$89KJul 1SEC ↗
Purchase$22KJul 1SEC ↗

Related companies

Shuttle Pharmaceuticals Holdings, Inc. is in the Healthcare sector.